The Fred Hutchinson Cancer Research Center (FHCRC) is a comprehensive, multi-disciplinary research center which uses basic and applied research to eliminate cancer as a cause of human suffering. Advances at the FHCRC in the areas of cancer prevention, diagnosis, and treatment are coupled with the progress made toward understanding the mechanisms of neoplastic development as well as basic aspects of cellular and molecular biology common to all organisms. The FHCRC employs over 2,300 faculty and staff and is organized into twenty collaborative programs: Biostatistics, Breast Cancer Research, Cancer Biology, Cancer Prevention Research, Cell Cycle and Growth Control, Clinical Transplant Research, Complications of Cancer Treatment, Developmental Biology, Epidemiology, Gastrointestinal Oncology, the developing program in Genetics, Human Immunogenetics, Immunology, Infectious Diseases, Molecular and Cellular Biology, Molecular Medicine, Molecular Pharmacology, Pediatric Oncology, the developing program in Prostate Cancer Research and Transplantation Biology. The high quality of research conducted in the scientific programs of the FHCRC is reflected in the level of funding from peer-reviewed, research grants and contracts. This application proposes continued support for Cancer Center Support Grant activities including senior leaders, program leaders, staff investigators, planning and evaluation, developmental funding, administration, protocol data review and monitoring, phase I/II trials and 20 shared resources.
The aims of the CCSG is to (1) provide support for the research infrastructure of the FHCRC and (2) promote and stimulate interdisciplinary research through enhanced collaborations among the scientific programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA015704-29S1
Application #
6553462
Study Section
Subcommittee G - Education (NCI)
Program Officer
Rosenfeld, Bobby
Project Start
1977-01-01
Project End
2002-12-31
Budget Start
2002-03-21
Budget End
2002-12-31
Support Year
29
Fiscal Year
2002
Total Cost
$42,695
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Liu, Yanyan; Xiong, Sican; Sun, Wei et al. (2018) Joint Analysis of Strain and Parent-of-Origin Effects for Recombinant Inbred Intercrosses Generated from Multiparent Populations with the Collaborative Cross as an Example. G3 (Bethesda) 8:599-605
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746
Glaser, Adam K; Chen, Ye; Yin, Chengbo et al. (2018) Multidirectional digital scanned light-sheet microscopy enables uniform fluorescence excitation and contrast-enhanced imaging. Sci Rep 8:13878
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Shirts, Brian H; Konnick, Eric Q; Upham, Sarah et al. (2018) Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. Am J Hum Genet 103:19-29
Kuzma, Jessica N; Hagman, Derek K; Cromer, Gail et al. (2018) Intra-individual variation in markers of intestinal permeability and adipose tissue inflammation in healthy normal weight to obese adults. Cancer Epidemiol Biomarkers Prev :

Showing the most recent 10 out of 1267 publications